Literature DB >> 8041708

Receptor to nucleus signaling by prolactin and interleukin 2 via activation of latent DNA-binding factors.

K C Gilmour1, N C Reich.   

Abstract

The mechanism of action of prolactin (PRL), a lactogenic and immunoregulatory hormone, has remained undetermined despite its critical role in development. This study identifies a DNA-binding factor induced by PRL that appears to mediate a signal from the cell surface receptor to specific gene expression in the nucleus. PRL stimulates the proliferation of Nb2 T-lymphoma cells and activates transcription of the interferon-regulatory factor 1 (IRF-1) gene. Within minutes of PRL stimulation, a PRL-induced factor (PRLIF) is activated and binds to a target site in the promoter of the IRF-1 gene. The PRLIF-binding site contains an inverted GAAA repeat that is also functional in the hormone-responsive beta-casein gene. The PRL-receptor complex signals tyrosine phosphorylation of JAK2, a nonreceptor tyrosine kinase, which may lead to activation of PRLIF. T-cell proliferation and transcriptional activation of the IRF-1 gene is also induced by the cytokine interleukin 2 (IL-2). This report demonstrates the rapid activation of an IL-2 nuclear-activated factor that recognizes the same GAAA inverted repeat in the IRF-1 promoter. PRLIF and IL-2 nuclear-activated factor are newly identified factors that appear to serve fundamental roles in the signal transduction pathways of PRL and IL-2, respectively, leading to the transcriptional regulation of responsive genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041708      PMCID: PMC44295          DOI: 10.1073/pnas.91.15.6850

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Inhibition of lymphocyte proliferation by antibodies to prolactin.

Authors:  D P Hartmann; J W Holaday; E W Bernton
Journal:  FASEB J       Date:  1989-08       Impact factor: 5.191

2.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

Authors:  C L Willman; C E Sever; M G Pallavicini; H Harada; N Tanaka; M L Slovak; H Yamamoto; K Harada; T C Meeker; A F List
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

3.  Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

Authors:  T Fujita; L F Reis; N Watanabe; Y Kimura; T Taniguchi; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes.

Authors:  P Mukherjee; A M Mastro; W C Hymer
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

5.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.

Authors:  H Harada; M Kitagawa; N Tanaka; H Yamamoto; K Harada; M Ishihara; T Taniguchi
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

6.  Effect of various protein kinase inhibitors on the induction of milk protein gene expression by prolactin.

Authors:  M Bayat-Sarmadi; L M Houdebine
Journal:  Mol Cell Endocrinol       Date:  1993-03       Impact factor: 4.102

7.  Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor.

Authors:  M J Gutch; C Daly; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein.

Authors:  K Shuai; C Schindler; V R Prezioso; J E Darnell
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

9.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements.

Authors:  M Miyamoto; T Fujita; Y Kimura; M Maruyama; H Harada; Y Sudo; T Miyata; T Taniguchi
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

10.  Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line.

Authors:  R K Ball; R R Friis; C A Schoenenberger; W Doppler; B Groner
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

View more
  16 in total

1.  Retinoic acid exerts dual regulatory actions on the expression and nuclear localization of interferon regulatory factor-1.

Authors:  Xin M Luo; A Catharine Ross
Journal:  Exp Biol Med (Maywood)       Date:  2006-05

2.  Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.

Authors:  L Matera; G Bellone; J J Lebren; P A Kelly; E L Hooghe Peters; P F Di Celle; R Foa; M Contarini; G Avanzi; V Asnaghi
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

3.  The role of the JAK-STAT pathway in neural stem cells, neural progenitor cells and reactive astrocytes after spinal cord injury.

Authors:  Tianyi Wang; Wenqi Yuan; Yong Liu; Yanjun Zhang; Zhijie Wang; Xianhu Zhou; Guangzhi Ning; Liang Zhang; Liwei Yao; Shiqing Feng; Xiaohong Kong
Journal:  Biomed Rep       Date:  2014-12-11

4.  Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation.

Authors:  M C Friedmann; T S Migone; S M Russell; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Blockade of the Short Form of Prolactin Receptor Induces FOXO3a/EIF-4EBP1-Mediated Cell Death in Uterine Cancer.

Authors:  Yunfei Wen; Ying Wang; Anca Chelariu-Raicu; Elaine Stur; Yuan Liu; Sara Corvigno; Faith Bartsch; Lauren Redfern; Behrouz Zand; Yu Kang; Jinsong Liu; Keith Baggerly; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2020-07-31       Impact factor: 6.261

6.  Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.

Authors:  K C Gilmour; R Pine; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity.

Authors:  S L Gaffen; S Y Lai; W Xu; F Gouilleux; B Groner; M A Goldsmith; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

8.  Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis.

Authors:  F W Quelle; K Shimoda; W Thierfelder; C Fischer; A Kim; S M Ruben; J L Cleveland; J H Pierce; A D Keegan; K Nelms
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

9.  The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes.

Authors:  S Y Lai; W Xu; S L Gaffen; K D Liu; G D Longmore; W C Greene; M A Goldsmith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

10.  Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ERα(+) tumorigenesis.

Authors:  S R Chan; C G Rickert; W Vermi; K C F Sheehan; C Arthur; J A Allen; J M White; J Archambault; S Lonardi; T M McDevitt; D Bhattacharya; M V Lorenzi; D C Allred; R D Schreiber
Journal:  Cell Death Differ       Date:  2013-09-13       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.